← Every applicant
Padagis Israel FDA Approvals
20 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NITROGLYCERINNew drugJul 6, 2026OINTMENT, INTRA-ANAL |
| TAZAROTENENew drugJul 29, 2025LOTION, TOPICAL |
| NALOXONE HYDROCHLORIDENew drugApr 24, 2025SPRAY, NASAL |
| PENCICLOVIRNew drugSep 27, 2024CREAM, TOPICAL |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDENew drugAug 20, 2024GEL, TOPICAL |
| TAZAROTENENew drugJul 15, 2024CREAM, TOPICAL |
| AZELASTINE HYDROCHLORIDENew drugMay 8, 2024SPRAY, METERED, NASAL |
| ESTRADIOLNew drugNov 14, 2023GEL, TRANSDERMAL |
| HALOBETASOL PROPIONATENew drugAug 11, 2023AEROSOL, FOAM, TOPICAL |
| TAZAROTENENew drugApr 25, 2023GEL, TOPICAL |
| BUDESONIDENew drugApr 12, 2023AEROSOL, FOAM, RECTAL |
| MUPIROCINNew drugAug 3, 2022CREAM, TOPICAL |
| NALOXONE HYDROCHLORIDENew drugJun 21, 2022SPRAY, METERED, NASAL |
| ADAPALENE AND BENZOYL PEROXIDENew drugMay 31, 2022GEL, TOPICAL |
| BETAMETHASONE DIPROPIONATENew drugApr 12, 2022OINTMENT, TOPICAL |
| ZOLMITRIPTANNew drugSep 30, 2021SPRAY, NASAL |
| BRIMONIDINE TARTRATENew drugSep 23, 2021GEL, TOPICAL |
| CLINDAMYCIN PHOSPHATENew drugMar 8, 2021LOTION, TOPICAL |
| AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATENew drugFeb 18, 2021SPRAY, METERED, NASAL |
| TRIAMCINOLONE ACETONIDENew drugFeb 5, 2021OINTMENT, TOPICAL |